after it had been provoked by rough handling. There were four small puncture wounds with transient numbness and paraesthesia but no specific measures were applied and the incident was soon forgotten. Next day he experienced mild nausea and malaise but continued to attend lectures and ward rounds as usual until alerted by passing black urine 20 hours after the bite. His blood was found to be incoagulable and he was admitted to this hospital for observation. There were r.) abnormal physical signs apart from minimal swelling around the site of the bite and slight jaundice. His urine contained glomerular casts and haemoglobin but no red cells. Fibrinogen was undetectable in his plasma by the gravimetric method and screening tests of coagulation were therefore unrecordable. Subsequent studies showed a depletion of other clotting factors (prothrombin 10°', factor V 17 factor VIIIC 12 ", , ) . The serum concentration of fibrinogen/fibrin degradation products was 512 mg/l; white blood count 8-6x 109/l (8600/mm3) with a normal differential count; platelet count 23 x 109/1 (23 000/mm3); and haemoglobin concentration was initially normal (figure). Haemoglobin and fibrinogen concentrations and platelet counts in patient suffering from snake envenomation.
Over the next two days a bleeding diathesis appeared with haematemeses, melaena, epistaxes, and massive extravasation of blood into the tissues around venepuncture sites. His haemoglobin concentration fell to 6 4 g/dl but pulse, blood pressure, and urine output remained stable. The blood film at this stage showed pronounced red cell fragmentation and microspherocytosis. Replacement therapy was started two days after admission and over the next four days he received a total of 10 units of blood, 10 units of fresh frozen plasma, 10 pools of platelet concentrate, and 4-2 g of fibrinogen. On the sixth day there were signs of improvement. Haemoglobin and platelet counts were maintained despite persisting blood film changes and hypofibrinogenaemia. Thereafter he recovered. The results of the coagulation tests became almost normal after two weeks. The snake was later identified as Rhabdophis submniniatus and its venom has been shown to clot plasma but not fibrinogen solution.2
Comment
The Rhabdophis genus has an envenomation apparatus in Duvernoy's glands and enlarged posterior maxillary teeth, but the latter are relatively small and inaccessible.:3 The snake had previously inflicted a superficial bite on another student with no ill effects. The bite sustained by TMM was deep and prolonged owing to his reluctance to injure a "harmless" pet by forcibly removing it, and this may have been necessary for envenomation. There are reports of similar cases after bites by the related R tigrinus (common in Japan and, again, generally considered innocuous), in which haemorrhage followed handling and a prolonged bite.4 We conclude that R subminiatus, which is freely imported into this country and sold as a non-venomous snake, is in fact highly venomous and particularly dangerous when handled. This may also apply to other species in the Rhabdophis genus and highlights the difficulties in distinguishing between venomous and non-venomous snakes.
We thank Professors J S Jenkins and P T Flute for permission to report this case, and Dr H A Reid and Dr N Arnold for advice and identification of the snake. Cimetidine for ulcers recurring after gastric surgery
The management of ulcers recurring after gastric surgery remains unsatisfactory.' Cimetidine aids healing of duodenal ulcers,2 but its effect on ulcers recurring after operation is not known. Recurrent ulcers differ from duodenal ulcers as they may occur with a peak acid output (PAO) as low as one mmol/hour.3 We have performed a study to discover if cimetidine will encourage healing of recurrent ulcers even if the acid output is low.
Patients, methods, and results
All patients referred for treatment of ulcers recurring after surgery for peptic ulcer were included in an "open" study of cimetidine. Twenty-two patients entered the trial, but two died before the end of treatment. Of the remaining 20, 14 had undergone vagotomy and pyloroplasty, five Billroth II partial gastrectomy, and one proximal gastric vagotomy. Their average age was 49 (range 18-70), and three were women. Endoscopy and pentagastrin tests were performed before treatment with cimetidine, 200 mg three times a day with meals and 400 mg at night. The patient's symptoms were assessed every fortnight. After six weeks endoscopy was repeated and if the ulcer had not healed a further six weeks' treatment was given and endoscopy repeated.
Before treatment five of the 20 patients had had stomal ulcers, 11 duodenal ulcers, and four gastric ulcers. Mean PAO was 23 4 mmol(mEq)/h (range 1-63 mmol/h). Five patients had a PAO of less than 10 mmol/h and three less than 2 5 mmol/h. A pentagastrin test was not performed on one patient. After six weeks' treatment 17 ulcers had healed, and after 12 weeks 19 had healed. One patient's ulcer was 2 mm in size and nearly healed at six weeks; he had no symptoms and refused further endoscopy. In 12 patients gastric biopsy specimens were obtained before and after treatment and the severity of gastritis was unchanged. Initially dyspepsia had occurred in 19 patients; this was abolished in seven patients after two weeks' treatment, in 17 after six weeks', and in all after 12 weeks' treatment. Despite ulcer healing, other symptoms persisted in four cases. In two they were minor: bile vomiting and "stabbing pain over the heart." The two remaining patients were dissatisfied with treatment. In one, dyspepsia was replaced by severe lower abdominal and chest pain. The other never had dyspepsia, and his lower abdominal pain and diarrhoea were not affected by healing of the gastric ulcer.
Discussion
This trial has the disadvantages of all studies which are not doubleblind. Nevertheless, the results suggest that cimetidine will aid healing of ulcers recurring after gastric surgery even if the PAO is low. Intragastric acidity was measured in one patient with a PAO of only 1 mmol/h; the pH was consistently below 2 and was effectively raised to above 5 oveinight by cimetidine. Therefore cimetidine does act by raising the intragastric pH even if PAO is low. Symptoms are relieved in most patients, but in a few some remain, and these may be functional. Results were satisfactory in 80% in this study, but only in 32% with previous medical treatment. ' Despite reports of possible acute vascular problems,4 cimetidine is unlikely to have caused the death of our two patients. One patient died of a pulmonary embolus only two days after starting cimetidine. The other patient aged 76 had ischaemic heart disease and severe peripheral vascular disease, and died suddenly, presumably of myocardial infarction due to his known atherosclerosis and unconnected with cimetidine.
Management ofpatients after the ulcer has healed remains uncertain. All of our patients were put on 400 mg of cimetidine at night; they have been followed now for two to 18 months and no ulcer has yet been known to have recurred. Further studies are needed to discover if long-term results are as good with cimetidine as with surgery.
Nevertheless, cimetidine may be used successfully in patients unfit for operation.
We thank Mr J Alexander-Williams and all the consultants who allowed us to include their patients in this study, and Smith, Kline, and French Laboratories Ltd for supplying the cimetidine tablets.
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The estimation of operative blood loss is open to large error. It is notoriously difficult to measure operative blood loss accurately and almost impossible to assess postoperative blood loss in most cases. trial to assess blood loss in patients undergoing this operation given subcutaneous heparin.
Patients, methods, and results
Sixty patients undergoing transurethral prostatectomy were randomly divided into two groups of 30. One group was given 5000 units of subcutaneous calcium heparin using single dose ampoules, 2 h before operation and then 12-hourly until the patient left hospital. The other group served as controls. The operations were carried out under general anaesthetic by one of two consultant urologists (JDJ, CJS), who were unaware of whether the patient was in the trial or was a control. Irrigating fluid was collected into a calibrated bath, and at the conclusion of the operation its volume was determined and a representative 10 ml sample of fluid taken for haemoglobin estimation. The prostatic chips were sent to the laboratory for histological examination and weighing.
A 24-hour urine collection was started at the time of catheter insertion at the end of the operation. Its volume was recorded and a representative sample of 10 ml removed for haemoglobin estimation. From these measurements, and knowing the preoperative haemoglobin, we could make an accurate estimate of blood loss during and after operation. Patients received an intravenous regimen for prevention of clot retention consisting of 4 g of epsilonaminocaproic acid in 1000 ml Hartmann's solution peroperatively;
EACA, 1 g per hour in normal saline postoperatively for 12 hours; and frusemide, 40 mg during operation followed by 20 mg four-hourly for 24 hours.4
The two groups were comparable in terms of age, mode of presentation, histological findings, and weight of gland. The average operative and 24-hour postoperative blood loss for the two groups is compared in the table. There was no significant difference in operative blood loss, but the postoperative blood loss in the heparin group was roughly twice that in the controls (P < 0-05). No significant difference in haemoglobin concentrations from the preoperative level to that on the second postoperative day was seen in the two groups, reflecting the laboratory error in such measurements. Six of the patients in the heparin group required transfusion of two units of blood each, whereas none in the control group did. No patient died and there were no clinical thromboembolic complications in either group.
Discussion
Blood loss during and after transurethral prostatectomy is extremely variable. Blood pressure, the vascularity and weight of the resected tissue, the duration of resection, the type of diathermy used, and the experience of the operator are the main influencing factors. The use of a standard normotensive anaesthetic, identical instruments, and similar resection techniques provided two groups in which the only difference was the administration of heparin. Hence undoubtedly prophylactic heparin, as used in this study, increases the operative morbidity and we can see no justification for its routine use in transurethral prostatectomy, a procedure with a low incidence of thromboembolic problems.
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